Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity

British Journal of Pharmacology

Volumn 132, Issue 8, 2001, Pages 1673-1682

  Steiner, A A ^a   Branco, L G S ^a   Cunha, F Q ^a   Ferreira, S H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carbon monoxide; Carrageenan; Cyclic GMP; Cytokines; Inflammatory hyperalgesia; Interleukin 1 (IL 1 ); Nitric oxide; Soluble guanylate cyclase; Tumour necrosis factor (TNF )

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CARBON MONOXIDE; DOPAMINE; GUANYLATE CYCLASE INHIBITOR; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; N(G) METHYLARGININE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC DEUTEROPORPHYRIN 2,4 BISGLYCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME MECHANISM; HYPERALGESIA; HYPERSENSITIVITY; INFLAMMATION; INJECTION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035036498     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704014     Document Type: Article

References (67)

1. Iron overload upregulates haem oxygenase 1 in the lung more rapidly than in other tissues
2. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations
3. Interleukin-8 as a mediator of sympathetic pain
4. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia
5. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4
6. Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP-on inflammatory hyperalgesia
7. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
8. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain
9. Peripheral analgesia and activation of the nitric oxidecyclic GMP pathway
10. Analgesia by direct antagonist of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway
11. Normal and Heat-induced patterns of expression of heme oxygenase-l (HSP32) in rat brain: Hyperthermia causes rapid induction of mRNA and protein
12. The molecular mechanism of action of peripheral morphine analgesia: Stimulation of the cGMP system via nitric oxide release
13. Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception
14. Interleukinl β as a potent hyperalgesic agent antagonized by a tripeptide analogue
15. Central and peripheral antialgesic action of aspirin-like drugs
16. Blockade of hyperalgesia and neurogenic oedema by topical application of nitroglycerin
17. ++ dependent process
18. Sustained hyperalgesia in rats evoked by the protein kinase inhibitor H7
19. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test
20. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat
21. Influences of algogenic substances on the discharges of unmyelinated cutaneous nerve fibres identified as nociceptor
22. Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system
23. Carbon monoxide: From toxin to endogenous modulator of cardiovascular functions
24. In vitro and in vivo induction of heine oxygenase-1 in rat glial cells: Possible involvement of nitric oxide from inducible nitric oxide synthase
25. Induction of inducible nitric oxide synthase and heme oxygenase-1 in rat glial cells
26. Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide
27. Oxytocin release is inhibited by the generation of carbon monoxide from the rat hypothalamus-further evidence for carbon monoxide as a neuromodulator
28. Stable analogues of cyclic AMP but not cyclic GMP sensitize unmyelinated primary afferents in rat skin to heat stimulation but not to inflammatory mediators, in vitro
29. Fate of haem after parenteral administration of haem arginate to rabbits
30. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia
31. Carbon monoxide: An emerging regulatory of cGMP in the brain
32. The heine oxygenase system: A regulator of second messenger gases
33. Spinal nitric oxide synthase inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats
34. Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkege between heme catabolism and neuroendocrine functions
35. The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1β from the rat hypothalamus in vitro: Evidence for the involvement of different signaling pathways
36. Does carbon monoxide have a physiological function?
37. L-arginine and calmodulin regulation of the heme iron reactivity in neuronal nitric oxide synthase
38. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat
39. G-Nitro-arginine methyl ester exhibits antinociceptive activity in the mouse
40. G-nitro arginine methyl ester (L-NAME) and flurbiprofen in the mouse
41. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell derived carbon monoxide
42. Smooth muscle cell-derived carbon monoxide is a regulator of cGMP
43. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
44. G-nitro arginine methyl ester-induced antinociception in mice: A role for serotonergic and adrenergic neurons
45. Prevention of halothane-induced hepatotoxicity by heroin pretreatment: Protective role of heine oxygenase-1 induction
46. Carbon monoxide modulates secretion of corticotropin-releasing factor (CRF) from rat hypothalamic cell cultures
47. Sensitization of nociceptors and its relation to sensation
48. Cell biology of heme
49. Carbon monoxide as a novel neuroendocrine modulator: Inhibition of stimulated corticotropin-releasing hormone release from acute hypothalamic explants
50. Cytokine induction of haem oxygenase mRNA in mouse liver
51. CO binding studies of nitric oxide synthase: Effects of the substrate, inhibitors and tetrahydrobiopterin
52. Regulation of heme oxygenase gene expression
53. Heme oxygenase-regulation of and physiological implication in heme catabolism
54. Endogenous formation of carbon monoxide in man under normal and pathological conditions
55. Central CO-heme oxygenase pathway raises body temperature by a prostaglandin-independent way
56. Carbon monoxide as a novel mediator of the febrile response in the central nervous system
57. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system
58. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia
59. Expression of heme oxygenase isozyme mRNA in the human brain and induction of heme oxygenase-1 by nitric oxide donors
60. Haem arginate: A new stable haem compound
61. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS
62. Mechanism of diclofenac analgesia: Direct blockade of inflammatory sensitization
63. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnPB
64. 2 in the rat is inhibited by guanosine 5′-O-(2-thiodiphosphate), 2′,5′-dideoxyadenosine and Walsh inhibitor peptide
65. Expression and modulatory effects of heme oxygenase in acute inflammation in the rat
66. Overview of HO-1 in inflammatory pathologies
67. Heme oxygenase: A novel target for the modulation of the inflammatory response